2022年张强/何冰/代文兵/王学清团队在纳米递送领域获系列进展

中国药学(英文版) ›› 2022, Vol. 31 ›› Issue (12): 959-962.

2022年张强/何冰/代文兵/王学清团队在纳米递送领域获系列进展

北京大学药学院天然药物及仿生药物国家重点实验室

北京大学药学院天然药物及仿生药物国家重点实验室

收稿日期:2022-12-20 修回日期:2022-12-20 接受日期:2022-12-20 出版日期:2022-12-27 发布日期:2022-12-29

In 2022 the research group of Prof. Qiang Zhang/Prof. Bing He/Prof. Wenbing Dai/Prof. Xueqing Wang have made a series of advances in the field of nanodelivery

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2022-12-20 Revised:2022-12-20 Accepted:2022-12-20 Online:2022-12-27 Published:2022-12-29

摘要/Abstract

摘要：

2022年, 北京大学药学院天然药物及仿生药物国家重点实验室张强/何冰/代文兵/王学清团队连续在纳米递送研究领域取得重要成果, 目前已在Advanced Materials (IF = 32.086)、Bioactive Materials (IF = 16.874)、Nanoscale Horizons (IF = 11.684)等国际权威学术杂志上发表了一系列研究文章。

Supporting:

北京大学药学院天然药物及仿生药物国家重点实验室. 2022年张强/何冰/代文兵/王学清团队在纳米递送领域获系列进展[J]. 中国药学(英文版), 2022, 31(12): 959-962.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. In 2022 the research group of Prof. Qiang Zhang/Prof. Bing He/Prof. Wenbing Dai/Prof. Xueqing Wang have made a series of advances in the field of nanodelivery[J]. Journal of Chinese Pharmaceutical Sciences, 2022, 31(12): 959-962.